Sk Biopharmaceuticals Co Ltd (326030) — Free Cash Flow Generation Index

Latest as of December 2025: 0.69x

Sk Biopharmaceuticals Co Ltd (326030) has a Free Cash Flow Generation Index of 0.69x as of December 2025. Free cash flow of ₩60.46 Billion represents 1% of operating cash flow (₩87.00 Billion). See Sk Biopharmaceuticals Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.69x

Free Cash Flow / Operating CF

Free Cash Flow

₩60.46 Billion

KRW

Operating Cash Flow

₩87.00 Billion

KRW

Capital Expenditures

₩26.55 Billion

KRW

Sk Biopharmaceuticals Co Ltd Free Cash Flow Generation Index (2024–2025)

Historical FCF Generation Index trend for Sk Biopharmaceuticals Co Ltd across 2 annual periods. Explore Sk Biopharmaceuticals Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Sk Biopharmaceuticals Co Ltd (2024–2025)

Year-by-year Free Cash Flow Generation Index for Sk Biopharmaceuticals Co Ltd. For the full company profile including market capitalisation, see Sk Biopharmaceuticals Co Ltd market cap and net worth.

Year	FCG Index	Free Cash Flow (KRW)	Operating CF	Capital Expenditures	YoY Change
2025	0.83x	₩146.82 Billion	₩176.33 Billion	₩29.51 Billion	▼ -3.0%
2024	0.86x	₩81.48 Billion	₩94.90 Billion	₩13.42 Billion	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).